Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DAVID ERIN BURNS

Allopathic & Osteopathic Physicians Internal Medicine Rheumatology

NPI
1295728590
CMS profile
103512
Location
HOUSTON, TX

General Payments · PY2018–2024

$6,354.41

  • Reported across 378 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$747.59

37 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $747.59 37

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Amgen Inc. $290.01 12
NOVARTIS PHARMACEUTICALS CORPORATION $108.37 4
Novo Nordisk AS $107.52 6
Radius Health, Inc. $69.56 4
Lilly USA, LLC $59.93 4
Janssen Biotech, Inc. $47.08 3
ABBVIE INC. $31.39 2
Aurinia Pharma U.S., Inc. $20.49 1
Acerta Pharma LLC $13.24 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $563.30 29
PY2019 $432.98 30
PY2020 $529.86 30
PY2021 $1,161.57 74
PY2022 $1,278.42 81
PY2023 $1,640.69 97
PY2024 $747.59 37

Payment records · PY2024 (37)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $17.06 01/23/2024 Food and Beverage Undisputed 01/23/2026 1103394399 CMS
ABBVIE INC. $14.33 04/03/2024 Food and Beverage Undisputed 01/23/2026 1103394401 CMS
Amgen Inc. $18.82 01/10/2024 Food and Beverage Undisputed 01/23/2026 1111539895 CMS
Amgen Inc. $31.83 01/26/2024 Food and Beverage Undisputed 01/23/2026 1111539897 CMS
Amgen Inc. $21.83 03/22/2024 Food and Beverage Undisputed 01/23/2026 1111539899 CMS
Amgen Inc. $29.59 04/17/2024 Food and Beverage Undisputed 01/23/2026 1111539901 CMS
Amgen Inc. $28.33 04/26/2024 Food and Beverage Undisputed 01/23/2026 1111539903 CMS
Amgen Inc. $28.57 05/08/2024 Food and Beverage Undisputed 01/23/2026 1111539905 CMS
Amgen Inc. $28.16 06/12/2024 Food and Beverage Undisputed 01/23/2026 1111539907 CMS
Amgen Inc. $26.60 07/17/2024 Food and Beverage Undisputed 01/23/2026 1111539909 CMS
Amgen Inc. $13.21 08/30/2024 Food and Beverage Undisputed 01/23/2026 1111539911 CMS
Amgen Inc. $26.34 10/15/2024 Food and Beverage Undisputed 01/23/2026 1111539913 CMS
Amgen Inc. $12.29 11/12/2024 Food and Beverage Undisputed 01/23/2026 1117214210 CMS
Amgen Inc. $24.44 11/19/2024 Food and Beverage Undisputed 01/23/2026 1117517690 CMS
AstraZeneca Pharmaceuticals LP $13.24 09/19/2024 Food and Beverage Undisputed 01/23/2026 1105473165 CMS
Aurinia Pharma U.S., Inc. $20.49 10/25/2024 Food and Beverage Undisputed 01/23/2026 1150677237 CMS
Janssen Biotech, Inc. $14.36 02/28/2024 Food and Beverage Undisputed 01/23/2026 1078721816 CMS
Janssen Biotech, Inc. $19.59 06/20/2024 Food and Beverage Undisputed 01/23/2026 1078720765 CMS
Janssen Biotech, Inc. $13.13 08/22/2024 Food and Beverage Undisputed 01/23/2026 1078721334 CMS
Lilly USA, LLC $13.43 01/11/2024 Food and Beverage Undisputed 01/23/2026 1136139739 CMS
Lilly USA, LLC $13.52 02/14/2024 Food and Beverage Undisputed 01/23/2026 1136143387 CMS
Lilly USA, LLC $18.43 05/22/2024 Food and Beverage Undisputed 01/23/2026 1136131678 CMS
Lilly USA, LLC $14.55 10/24/2024 Food and Beverage Undisputed 01/23/2026 1136152305 CMS
Novartis Pharmaceuticals Corporation $26.15 08/20/2024 Food and Beverage Undisputed 01/23/2026 1086681737 CMS
Novartis Pharmaceuticals Corporation $31.04 09/24/2024 Food and Beverage Undisputed 01/23/2026 1086681747 CMS
Novartis Pharmaceuticals Corporation $26.08 10/23/2024 Food and Beverage Undisputed 01/23/2026 1086681753 CMS
Novartis Pharmaceuticals Corporation $25.10 11/05/2024 Food and Beverage Undisputed 01/23/2026 1086681755 CMS
Novo Nordisk Inc $13.99 01/21/2024 Food and Beverage Undisputed 01/23/2026 1097033048 CMS
Novo Nordisk Inc $16.79 02/28/2024 Food and Beverage Undisputed 01/23/2026 1097320820 CMS
Novo Nordisk Inc $20.47 03/08/2024 Food and Beverage Undisputed 01/23/2026 1096993689 CMS
Novo Nordisk Inc $17.45 06/18/2024 Food and Beverage Undisputed 01/23/2026 1097578306 CMS
Novo Nordisk Inc $18.39 08/15/2024 Food and Beverage Undisputed 01/23/2026 1097245195 CMS
Novo Nordisk Inc $20.43 11/20/2024 Food and Beverage Undisputed 01/23/2026 1097150918 CMS
Radius Health, Inc. $16.17 02/22/2024 Food and Beverage Undisputed 01/23/2026 1089945736 CMS
Radius Health, Inc. $20.83 04/11/2024 Food and Beverage Undisputed 01/23/2026 1089945732 CMS
Radius Health, Inc. $16.28 08/08/2024 Food and Beverage Undisputed 01/23/2026 1089945742 CMS
Radius Health, Inc. $16.28 10/04/2024 Food and Beverage Undisputed 01/23/2026 1089945749 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.